BACKGROUND: Positron emission tomography (PET) with (18)F-fluorodeoxyglucose (FDG) shows widespread hypometabolism even in temporal lobe epilepsy (TLE) patients with mesial temporal foci. (18)F-trans-4-fluoro-N-2-[4-(2-methoxyphenyl) piperazin-1-yl]ethyl-N-(2-pyridyl)cyclohexane carboxamide ((18)F-FCWAY) PET may show more specific 5-HT(1A)-receptor binding reduction in seizure initiation than in propagation regions. (18)FCWAY PET might be valuable for detecting epileptic foci, and distinguishing mesial from lateral temporal foci in MRI-negative patients with TLE. METHODS: We performed (18)F-FCWAY-PET and (18)F-FDG-PET in 12 MRI-negative TLE patients who had had either surgery or subdural electrode recording, and 15 healthy volunteers. After partial volume correction for brain atrophy, free fraction-corrected volume of distribution (V/f1) measurement and asymmetry indices (AIs) were computed. We compared (18)F-FCWAY-PET and (18)F-FDG-PET results with scalp video electroencephalography (EEG), invasive EEG, and surgical outcome. RESULTS: Mean (18)F-FCWAY V/f1, compared with normal controls, was decreased significantly in fusiform gyrus, hippocampus, and parahippocampus ipsilateral to epileptic foci, and AIs were significantly greater in hippocampus, parahippocampus, fusiform gyrus, amygdala, and inferior temporal regions. Eleven patients had clearly lateralized epileptogenic zones. Nine had congruent, and two nonlateralized, (18)F-FCWAY PET. One patient with bitemporal seizure onset had nonlateralized (18)F-FCWAY-PET. (18)F-FDG-PET showed congruent hypometabolism in 7 of 11 EEG-lateralized patients, bilateral hypometabolic regions in one, contralateral hypometabolism in one, as well as lateralized hypometabolism in the patient with bitemporal subdural seizure onset. Patients with mesial temporal foci tended to have lower superior and midtemporal (18)F-FCWAY V/f1 binding AI than those with lateral or diffuse foci. CONCLUSION: (18)F-FCWAY-PET can detect reduced binding in patients with normal MRI, and may be more accurate than (18)F-FDG-PET.
BACKGROUND: Positron emission tomography (PET) with (18)F-fluorodeoxyglucose (FDG) shows widespread hypometabolism even in temporal lobe epilepsy (TLE) patients with mesial temporal foci. (18)F-trans-4-fluoro-N-2-[4-(2-methoxyphenyl) piperazin-1-yl]ethyl-N-(2-pyridyl)cyclohexane carboxamide ((18)F-FCWAY) PET may show more specific 5-HT(1A)-receptor binding reduction in seizure initiation than in propagation regions. (18)FCWAY PET might be valuable for detecting epileptic foci, and distinguishing mesial from lateral temporal foci in MRI-negative patients with TLE. METHODS: We performed (18)F-FCWAY-PET and (18)F-FDG-PET in 12 MRI-negative TLEpatients who had had either surgery or subdural electrode recording, and 15 healthy volunteers. After partial volume correction for brain atrophy, free fraction-corrected volume of distribution (V/f1) measurement and asymmetry indices (AIs) were computed. We compared (18)F-FCWAY-PET and (18)F-FDG-PET results with scalp video electroencephalography (EEG), invasive EEG, and surgical outcome. RESULTS: Mean (18)F-FCWAY V/f1, compared with normal controls, was decreased significantly in fusiform gyrus, hippocampus, and parahippocampus ipsilateral to epileptic foci, and AIs were significantly greater in hippocampus, parahippocampus, fusiform gyrus, amygdala, and inferior temporal regions. Eleven patients had clearly lateralized epileptogenic zones. Nine had congruent, and two nonlateralized, (18)F-FCWAY PET. One patient with bitemporal seizure onset had nonlateralized (18)F-FCWAY-PET. (18)F-FDG-PET showed congruent hypometabolism in 7 of 11 EEG-lateralized patients, bilateral hypometabolic regions in one, contralateral hypometabolism in one, as well as lateralized hypometabolism in the patient with bitemporal subdural seizure onset. Patients with mesial temporal foci tended to have lower superior and midtemporal (18)F-FCWAY V/f1 binding AI than those with lateral or diffuse foci. CONCLUSION: (18)F-FCWAY-PET can detect reduced binding in patients with normal MRI, and may be more accurate than (18)F-FDG-PET.
Authors: Yu Kyeong Kim; Dong Soo Lee; Sang Kun Lee; Seok-Ki Kim; Chun Kee Chung; Ki Hyun Chang; Ki Young Choi; June-Key Chung; Myung Chul Lee Journal: J Nucl Med Date: 2003-07 Impact factor: 10.057
Authors: G D Cascino; C R Jack; J E Parisi; F W Sharbrough; K A Hirschorn; F B Meyer; W R Marsh; P C O'Brien Journal: Ann Neurol Date: 1991-07 Impact factor: 10.422
Authors: Sabine G Uijl; Frans S S Leijten; Johan B A M Arends; Jaime Parra; Alexander C van Huffelen; Karel G M Moons Journal: Epilepsia Date: 2007-07-25 Impact factor: 5.864
Authors: Barbara E Swartz; Charles Brown; Mark A Mandelkern; Ali Khonsari; Ashok Patell; Ken Thomas; Denise Torgersen; A V Delgado-Escueta; Gregory O Walsh Journal: Mol Imaging Biol Date: 2002-05 Impact factor: 3.488
Authors: M Franceschi; G Lucignani; A Del Sole; C Grana; S Bressi; F Minicucci; C Messa; M P Canevini; F Fazio Journal: J Neurol Neurosurg Psychiatry Date: 1995-10 Impact factor: 10.154
Authors: William H Theodore; Edythe A Wiggs; Ashley R Martinez; Irene H Dustin; Omar I Khan; Shmuel Appel; Pat Reeves-Tyer; Susumu Sato Journal: Epilepsia Date: 2011-11-02 Impact factor: 5.864
Authors: Jussi Hirvonen; William C Kreisl; Masahiro Fujita; Irene Dustin; Omar Khan; Shmuel Appel; Yi Zhang; Cheryl Morse; Victor W Pike; Robert B Innis; William H Theodore Journal: J Nucl Med Date: 2012-01-11 Impact factor: 10.057
Authors: William H Theodore; Ashley R Martinez; Omar I Khan; Clarissa J Liew; Sungyoung Auh; Irene M Dustin; John Heiss; Susumu Sato Journal: J Nucl Med Date: 2012-07-10 Impact factor: 10.057
Authors: Pablo Bascuñana; Mirjam Brackhan; Ina Leiter; Heike Keller; Ina Jahreis; Tobias L Ross; Frank M Bengel; Marion Bankstahl; Jens P Bankstahl Journal: J Cereb Blood Flow Metab Date: 2018-10-30 Impact factor: 6.200
Authors: Louise M Paterson; Birgitte R Kornum; David J Nutt; Victor W Pike; Gitte M Knudsen Journal: Med Res Rev Date: 2011-06-14 Impact factor: 12.944
Authors: Wesley T Kerr; Stefan T Nguyen; Andrew Y Cho; Edward P Lau; Daniel H Silverman; Pamela K Douglas; Navya M Reddy; Ariana Anderson; Jennifer Bramen; Noriko Salamon; John M Stern; Mark S Cohen Journal: Front Neurol Date: 2013-04-03 Impact factor: 4.003